How about taking a comprehensive look at what the FDA has been doing and not doing?
That's a far better focus for what's gone wrong.
Blaming SI and MSB management is just falling in line with what the downrampers and shorters want.
The more you do this the more the lack of confidence and the SP gets punished.
I'm not saying it s your duty to pump the SP, far from it.
But it's also worthwhile thinking about the impact of the venting.
Ann: Mesoblast Type A Meeting with FDA, page-448
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.020(1.45%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.41 | $1.38 | $1.585M | 1.134M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 7754 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 9488 | 8 |
View Market Depth
| Last trade - 11.58am 17/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |